Allergan INC (Formerly Actavis INC )
Pharmaceutical manufacturer specializing in generic, brand and biosimilar products.
Based in DC
AI Overview
With $520K in lobbying spend across 10 quarterly filings, Allergan INC (Formerly Actavis INC ) is an active lobbying client. Their lobbying covers 5 issue areas. Active from 2018 to 2020.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Allergan INC (Formerly Actavis INC ) disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Copyright/Patent, Taxation, Health Issues, Budget/Appropriations
Monitor issues concerning bioequivalence standards for pharmaceuticals.
Advocate for Inter Partes Review (IPR) reform concerning pharmaceuticals.
Monitor technical corrections to H.R. 1, the Tax Cuts and Jobs Act.
Advocate for voluntary best practices related to pharmaceutical pricing. Engage with policymakers on Medicare Part D prescription drug benefit as related to HR 1892, the Bipartisan Budget Act of 2018.
Advocate for FDA oversight of compounded medicines as related to the HR 1625, the Consolidated Appropriations Act of 2018.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.